| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
hsa-miR-3151-5p, hsa-miR-6791-5p, hsa-miR-939-5p, hsa-miR-637, hsa-miR-7974 |
| Biological function: |
Potential diagnostic biomarker for ET2DN |
| Molecular mechanism: |
Predicted circRNA-microRNA-mRNA interaction network (ceRNA-like); mechanism not experimentally validated |
| Biological pathway or process: |
ceRNA regulation (other); not specified |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
ROC curve analysis showed high diagnostic value for ET2DN (AUC 0.95; sensitivity 0.85; specificity 0.85). |
| Description: |
hsa_circ_0001831 is significantly up-regulated in peripheral blood of ET2DN patients versus T2DM and controls and shows strong diagnostic performance by ROC analysis. The study predicts a circRNA-miRNA-mRNA interaction network (including hsa-miR-3151-5p, hsa-miR-6791-5p, hsa-miR-939-5p, hsa-miR-637, hsa-miR-7974) but does not experimentally validate downstream targets. |
| Confidence score: |
0.5963 |